Chronic administration of quetiapine stimulates dorsal hippocampal proliferation and immature neurons of male rats, but does not reverse psychosocial stress-induced hyponeophagic behavior. (February 2019)

• Record Type: Journal Article
• Authors: Murata, Yusuke; Matsuda, Hiroko; Mikami, Yoko; Hirose, Shiori; Mori, Masayoshi; Ohe, Kenji; Mine, Kazunori; Enjoji, Munechika
• Is Part Of: Psychiatry research. Volume 272(2019)
• Page Start: 411
• Page End: 418
• Publication Date: 2019-02
• Subjects: Dorsoventral axis -- Novelty-Suppressed Feeding test -- Regional differences -- Social defeat; Psychiatry -- Periodicals; Psychiatry -- periodicals; Psychiatrie -- Périodiques; 616.89
• DOI: 10.1016/j.psychres.2018.12.137
• Languages: English
• ISSNs: 0165-1781

Abstract

Highlights: Regional differences in hippocampal neurogenesis (NG) were assessed in male rats. Chronic quetiapine (QTP) treatment exclusively stimulated dorsal hippocampal NG. QTP did not block the social defeat-induced decrease in NG of ventral hippocampus. Stress-induced hyponeophagia was not reversed by chronic administration of QTP. Abstract: Quetiapine, an atypical antipsychotic, has been used for the treatment of several neuropsychiatric disorders. However, the underlying mechanism of the broad therapeutic range of quetiapine remains unknown. We previously reported that several aversive conditions affect dorsal/ventral hippocampal neurogenesis differentially. This study was aimed to elucidate the positive effects of chronic treatment with quetiapine on regional differences in hippocampal proliferation and immature neurons and behavioral changes under psychosocial stress using the Resident-Intruder paradigm. Twenty-three male Sprague-Dawley rats were intraperitoneally administered a vehicle or quetiapine (10 mg/kg) once daily for 28 days. Two weeks after starting the injections, animals were exposed to intermittent social defeat (four times over two weeks). The behavioral effects of stress and quetiapine were evaluated by the Novelty-Suppressed Feeding (NSF) test. The stereological quantification of hippocampal neurogenesis was estimated using immunostaining with Ki-67 and doublecortin (DCX). Chronic quetiapine treatment stimulated the Ki-67- and DCX-positive cells in the dorsal hippocampus, but not in the ventral subregion. The stress-induced changes in neurogenesis and hyponeophagic behavior were not reversed by repeated administration of quetiapine. Future study with additional behavioral tests is needed to elucidate the functional significance of the quetiapine-induced increase in dorsal hippocampal neurogenesis.